Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avari Medical is a private Canadian medical aesthetics company focused on commercializing science-backed skincare, regenerative-aesthetic products, and capital equipment for clinics across Canada. The company operates primarily as a distributor and supplier rather than a drug developer, with a portfolio that includes brands such as Epicutis, Purasomes, and Neauvia-associated devices including Zaffiro, Sectum, Plasma IQ, EpilME, and LaserME. It also markets ACORN, a non-invasive hair-follicle stem cell banking service positioned for future personalized regenerative medicine use. Avari emphasizes customer service, education, and access to innovative aesthetic products for physician practices and other aesthetic medicine providers. Based on the available information, the business is commercial-stage and focused on the Canadian aesthetic healthcare market rather than traditional therapeutic biopharma R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avari Medical.